{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:35:02Z","timestamp":1792798502553,"version":"4.5.0"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>This review examines the strong association between metabolic dysfunction-associated steatotic liver disease (MASLD) and osteoporosis (OP), with a particular focus on the role of gut microbiota in linking these two disorders. Both MASLD and OP are closely linked to metabolic syndrome, and their pathogenesis involves multiple factors, such as inflammatory response, insulin resistance, altered intestinal permeability, and estrogen deficiency. Dysregulation of gut microbiota not only affects hepatic fat accumulation and bone metabolism disorders through metabolites, such as short-chain fatty acids, but also exacerbates systemic chronic inflammation by impairing the intestinal barrier function, thus accelerating the progression of both diseases. This article summarizes recent studies that highlight the central role of gut microbiota as a co-morbid factor in MASLD and OP, offering new perspectives for future diagnostic and therapeutic strategies.<\/jats:p>","DOI":"10.3389\/fendo.2025.1543003","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T09:11:11Z","timestamp":1743498671000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Unraveling the link between metabolic dysfunction-associated steatotic liver disease and osteoporosis: a bridging function of gut microbiota"],"prefix":"10.3389","volume":"16","author":[{"given":"Jing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingzi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202401_35052","article-title":"Causal link between gut microbiota and osteoporosis analyzed via Mendelian randomization","volume":"28","author":"Zeng","year":"2024","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1278505","article-title":"Associations of metabolic dysfunction-associated fatty liver disease and hepatic fibrosis with bone mineral density and risk of osteopenia\/osteoporosis in T2DM patients","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"S1043276024000365","DOI":"10.1016\/j.tem.2024.02.007","article-title":"Current status and future trends of the global burden of MASLD","author":"Miao","year":"2024","journal-title":"Trends Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1055\/a-1862-9088","article-title":"Nonalcoholic fatty liver disease: current global burden","volume":"42","author":"El-Kassas","year":"2022","journal-title":"Semin Liver Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106635","article-title":"Cell death regulation: A new way for natural products to treat osteoporosis","volume":"187","author":"Li","year":"2023","journal-title":"Pharmacol Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2019.100946","article-title":"Gut microbiota and osteoarthritis management: An expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO)","volume":"55","author":"Biver","year":"2019","journal-title":"Ageing Res Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-017-3909-3","article-title":"Worldwide prevalence and incidence of osteoporotic vertebral fractures","volume":"28","author":"Ballane","year":"2017","journal-title":"Osteoporos Int"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-10-675173","article-title":"Peptidoglycan from the gut microbiota governs the lifespan of circulating phagocytes at homeostasis","volume":"127","author":"Hergott","year":"2016","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000032499","article-title":"Exploring the regulatory mechanism of osteoporosis based on intestinal flora: A review","volume":"101","author":"Awuti","year":"2022","journal-title":"Medicine"},{"key":"B12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41577-019-0198-4","article-title":"The intestinal microbiota fuelling metabolic inflammation","volume":"20","author":"Tilg","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106507","article-title":"Toll-like receptors and metabolic (dysfunction)-associated fatty liver disease","volume":"185","author":"Khanmohammadi","year":"2022","journal-title":"Pharmacol Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v8.i32.1354","article-title":"Toll-like receptors in pathophysiology of liver diseases","volume":"8","author":"Kiziltas","year":"2016","journal-title":"World J Hepatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abe1692","article-title":"Hepatocyte TLR4 triggers inter-hepatocyte Jagged1\/Notch signaling to determine NASH-induced fibrosis","volume":"13","author":"Yu","year":"2021","journal-title":"Sci Transl Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s13679-023-00505-4","article-title":"Osteoprotegerin\/receptor activator of nuclear factor-kappa B ligand\/receptor activator of nuclear factor-kappa B axis in obesity, type 2 diabetes mellitus, and nonalcoholic fatty liver disease","volume":"12","author":"Vachliotis","year":"2023","journal-title":"Curr Obes Rep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.maturitas.2017.06.025","article-title":"Estrogen-gut microbiome axis: Physiological and clinical implications","volume":"103","author":"Baker","year":"2017","journal-title":"Maturitas"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI9575","article-title":"Altered expression of fatty acid\u2013metabolizing enzymes in aromatase-deficient mice","volume":"105","author":"Nemoto","year":"2000","journal-title":"J Clin Invest"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000000500","article-title":"Surgical menopause and increased risk of nonalcoholic fatty liver disease in endometrial cancer","volume":"23","author":"Matsuo","year":"2016","journal-title":"Menopause"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065814","article-title":"Hormone-related and drug-induced osteoporosis: A cellular and molecular overview","volume":"24","author":"Wang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106930","article-title":"Estrogen deficiency induces bone loss through the gut microbiota","volume":"196","author":"Guan","year":"2023","journal-title":"Pharmacol Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1172\/JCI86062","article-title":"Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics","volume":"126","author":"Li","year":"2016","journal-title":"J\u00a0Clin Invest"},{"key":"B23","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1038\/s41467-021-24331-1","article-title":"Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer","volume":"12","author":"Luu","year":"2021","journal-title":"Nat Commun"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13663","article-title":"Management of type 2 diabetes, obesity, or nonalcoholic steatohepatitis with high-dose GLP-1 receptor agonists and GLP-1 receptor-based co-agonists","volume":"25","author":"Goldenberg","year":"2024","journal-title":"Obes Rev"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2015.128","article-title":"Short-chain fatty acids in control of body weight and insulin sensitivity","volume":"11","author":"Canfora","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/nu15173736","article-title":"Positive regulation of acetate in adipocyte differentiation and lipid deposition in obese mice","volume":"15","author":"Sun","year":"2023","journal-title":"Nutrients"},{"key":"B27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40779-022-00404-0","article-title":"Propionate and butyrate attenuate macrophage pyroptosis and osteoclastogenesis induced by CoCrMo alloy particles","volume":"9","author":"Wu","year":"2022","journal-title":"Mil Med Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(78)90305-7","article-title":"Sodium butyrate inhibits histone deacetylation in cultured cells","volume":"14","author":"Candido","year":"1978","journal-title":"Cell"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e28435","article-title":"Microbiota metabolites in bone: Shaping health and Confronting disease","volume":"10","author":"Han","year":"2024","journal-title":"Heliyon"},{"key":"B30","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jot.2022.08.003","article-title":"Fecal microbiota transplantation ameliorates bone loss in mice with ovariectomy-induced osteoporosis via modulating gut microbiota and metabolic function","volume":"37","author":"Zhang","year":"2022","journal-title":"J Orthop Translat"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1172\/JCI133473","article-title":"Parathyroid hormone-dependent bone formation requires butyrate production by intestinal microbiota","volume":"130","author":"Li","year":"2020","journal-title":"J Clin Invest"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/nri3608","article-title":"Intestinal epithelial cells: regulators of barrier function and immune homeostasis","volume":"14","author":"Peterson","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1053\/j.gastro.2016.06.022","article-title":"Loss of junctional adhesion molecule A promotes severe steatohepatitis in mice on a diet high in saturated fat, fructose, and cholesterol","volume":"151","author":"Rahman","year":"2016","journal-title":"Gastroenterology"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1096\/FASEBJ.2021.35.S1.02729","article-title":"Gut microbiota accelerates bone growth and marrow adiposity of the adolescent gnotobiotic rat","volume":"35","author":"Golonka","year":"2021","journal-title":"FASEB J"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.90696.2008","article-title":"Inflammatory bowel disease causes reversible suppression of osteoblast and chondrocyte function in mice","volume":"296","author":"Harris","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"m4747","DOI":"10.1136\/bmj.m4747","article-title":"Management of non-alcoholic fatty liver disease","author":"Petroni","year":"2021","journal-title":"BMJ"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1172\/JCI125915","article-title":"RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass","volume":"129","author":"Bonnet","year":"2019","journal-title":"J Clin Invest"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012835","article-title":"Increased risk of osteoporosis in patients with nonalcoholic fatty liver disease: A population-based retrospective cohort study","volume":"97","author":"Chen","year":"2018","journal-title":"Medicine"},{"key":"B39","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1186\/s13018-023-04385-1","article-title":"Association of TNF-\u03b1, IGF-1, and IGFBP-1 levels with the severity of osteopenia in mice with nonalcoholic fatty liver disease","volume":"18","author":"Wang","year":"2023","journal-title":"J Orthop Surg Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2018.1465157","article-title":"The human gut microbiota: Metabolism and perspective in obesity","volume":"9","author":"Gomes","year":"2018","journal-title":"Gut Microbes"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"B42","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1530\/JOE-15-0333","article-title":"Obesity does not aggravate osteoporosis or osteoblastic insulin resistance in orchiectomized rats","volume":"228","author":"Potikanond","year":"2016","journal-title":"J Endocrinol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.554604","article-title":"Association of insulin resistance and \u03b2-cell function with bone turnover biomarkers in dysglycemia patients","volume":"12","author":"Guo","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B44","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1210\/jc.2015-3451","article-title":"Insulin resistance negatively influences the muscle-dependent IGF-1-bone mass relationship in premenarcheal girls","volume":"101","author":"Kindler","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e0203223","DOI":"10.1128\/mbio.02032-23","article-title":"Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases","volume":"15","author":"Zeng","year":"2024","journal-title":"mBio"},{"key":"B46","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1172\/JCI88880","article-title":"Skeletal muscle inflammation and insulin resistance in obesity","volume":"127","author":"Wu","year":"2017","journal-title":"J Clin Invest"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2028395","article-title":"NN9931-4296 investigators. A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N Engl J Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2017.09.018","article-title":"Liraglutide, a glucagon-like peptide-1 receptor agonist, facilitates osteogenic proliferation and differentiation in MC3T3-E1 cells through phosphoinositide 3-kinase (PI3K)\/protein kinase B (AKT), extracellular signal-related kinase (ERK)1\/2, and cAMP\/protein kinase A (PKA) signaling pathways involving \u03b2-catenin","volume":"360","author":"Wu","year":"2017","journal-title":"Exp Cell Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2016.02.002","article-title":"Activation of GLP-1 receptor promotes bone marrow stromal cell osteogenic differentiation through \u03b2-catenin","volume":"6","author":"Meng","year":"2016","journal-title":"Stem Cell Rep"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e20211872","DOI":"10.1084\/jem.20211872","article-title":"Dnmt3a -mutated clonal hematopoiesis promotes osteoporosis","volume":"218","author":"Kim","year":"2021","journal-title":"J Exp Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103120","article-title":"Significance of IL-7 and IL-7R in RA and autoimmunity","volume":"21","author":"Meyer","year":"2022","journal-title":"Autoimmun Rev"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01376","article-title":"Interleukin-7 induces osteoclast formation via STAT5, independent of receptor activator of NF-kappaB ligand","volume":"8","author":"Kim","year":"2017","journal-title":"Front Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25179193","article-title":"RANK\u2013RANKL\u2013OPG axis in MASLD: current evidence linking bone and liver diseases and future perspectives","volume":"25","author":"Monti","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s13679-024-00586-9","article-title":"Osteokines in nonalcoholic fatty liver disease","volume":"13","author":"Vachliotis","year":"2024","journal-title":"Curr Obes Rep"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2437250","article-title":"Alterations of gut virome with close interaction in the progression of estrogen deficiency-induced osteoporosis","volume":"16","author":"Chen","year":"2024","journal-title":"Gut Microbes"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1342356","article-title":"Research reviews and prospects of gut microbiota in liver cirrhosis: a bibliometric analysis (2001\u20132023)","volume":"15","author":"Zhu","year":"2024","journal-title":"Front Microbiol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14315","article-title":"The connection between aging, cellular senescence and gut microbiome alterations: A comprehensive review","volume":"23","year":"2024","journal-title":"Aging Cell"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.4c17985","article-title":"Enhanced Osteoporosis Treatment via Nano Drug Coating Encapsulating Lactobacillus rhamnosus GG","volume":"17","author":"Mehvish","year":"2025","journal-title":"ACS Appl Mater Interfaces"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.11.008","article-title":"Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice","volume":"66","author":"Ferrere","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.24636","article-title":"Probiotic L. reuteri treatment prevents bone loss in a menopausal ovariectomized mouse model","volume":"229","author":"Britton","year":"2014","journal-title":"J\u00a0Cell Physiol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1543003\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T09:11:13Z","timestamp":1743498673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1543003\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":60,"alternative-id":["10.3389\/fendo.2025.1543003"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1543003","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"article-number":"1543003"}}